Element Biosciences has secured $175 million in a Series E funding round, led by Samsung Electronics, to accelerate the commercialization of its genomic and multiomic solutions. This follow-on round will fuel global expansion and advance its product roadmap for research, translational science, and diagnostic applications. The company aims to leverage this capital to further develop its innovative technologies.
Amount: $175.0M
